Eli Lilly weight loss pill shows promise in latest clinical trial, company says

Eli Lilly, the maker of Zepbound and Mounjaro, said its experimental GLP-1 pill successfully helped adults…

Ozempic maker Novo Nordisk wants the FDA to stop pharmacies from making off-brand versions of popular weight loss meds

In This Story Ozempic maker Novo Nordisk (NVO-0.61%) is asking the U.S. Food and Drug Administration…